Journal
EXPERIMENTAL AND THERAPEUTIC MEDICINE
Volume 11, Issue 5, Pages 1700-1706Publisher
SPANDIDOS PUBL LTD
DOI: 10.3892/etm.2016.3143
Keywords
metformin; mitochondria; mediated pathway; apoptosis; breast cancer
Categories
Funding
- Natural Science Foundation of China [81272739]
Ask authors/readers for more resources
Breast cancer is the most commonly occurring cancer and second leading cause of mortality in women. Metformin is a widely prescribed anti-hyperglycemic drug, which is emerging as a potential cancer preventative and treatment agent. However, the mechanisms underlying the suppressive effects of metformin on cancer cell growth and the induction of cancer cell apoptosis are not fully elucidated. The present study aimed to identify the pathways regulated by metformin in two breast cancer cell lines, MDA-MB-231 and MDA-MB-435. Cells were treated with various concentrations of metformin and then evaluated with respect to viability, proliferation, adenosine triphosphate (ATP) and reactive oxygen species (ROS) levels, mitochondrial membrane potential (Delta psi m), and the expression of anti-and pro-apoptotic proteins. Metformin caused apoptosis in a concentration-and time-dependent manner, and decreased cell viability and ATP production. Furthermore, metformin induced the generation of ROS and decreased the Delta psi m. Moreover, metformin down-regulated the expression of the anti-apoptotic proteins B-cell lymphoma 2 (BCL-2) and myeloid cell leukemia-1, and upregulated the expression of the pro-apoptotic BCL-2-associated X protein in MDA-MB-231 cells. These results demonstrate that the apoptotic and cytotoxic effects of metformin on breast cancer cells are mediated by the intrinsic mitochondriamedi-ated apoptosis pathway.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available